United Kingdom · Question · Written question
UIN 73912
Tirzepatide
Introduced
1 September 2025
Last action
9 September 2025 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
9 September 2025
Summary
To ask the Secretary of State for Health and Social Care, with reference to NHS England’s publication entitled Interim commissioning guidance: Implementation of the NICE Technology Appraisal TA1026 and the NICE funding variation for tirzepatide (Mounjaro)
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
1 September 2025
Written question
To ask the Secretary of State for Health and Social Care, with reference to NHS England’s publication entitled Interim commissioning guidance: Implementation of the NICE Technology Appraisal TA1026 and the NICE funding variation for tirzepatide (Mounjaro)
Source: Commons
9 September 2025
Answer
The National Institute for Health and Care Excellence (NICE) is the independent body responsible for developing evidence-based guidance for the National Health Service on the use of licensed medicines based on an assessment of their clinical and cost-effe...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2025-09-01/73912
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1830695
- uk · wq-1830695 · source updated 9 September 2025